Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-18 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-16 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-12 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-11 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-08 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-07 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-07 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-06 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |